Penumbra, Inc. (PEN) stock analysis

In our weekly check, Penumbra, Inc. is graded A (A to F). Of 19 checks on debt, profit, cash flow and trend: 17 pass, warnings: 1, red flags: 1.

Sector: Healthcare · Medical Devices

Strengths

• Low debt
• Easily covers interest
• Margins rising
• Profits backed by cash
• Strong free cash flow

Warning signs

• High P/E
• Thinly traded

Next earnings report: 2026-11-04

Similar companies

ALGN · GMED · BIO-B · GKOS · BRKR · ZBH

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks graded D or F lost a third of their value 2-3 times as often as those graded A or B.

Updated 2026-10-03

Open the full analysis